Hot Features
Premium
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Cocrystal Pharma Inc | COCP | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 1,55 | 10:05:51 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 1,55 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1,325 - 3,285 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 1,55 | USD |
Finanzwerte COCP
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 15,77M | 10,17M | - | 2,6M | -17,98M | -1,77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Cocrystal Pharma
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 28.3.2024 | 13:00 | GlobeNewswire Inc. | Cocrystal Pharma Reports 2023 Financial Results and Provides.. |
| 19.3.2024 | 13:00 | GlobeNewswire Inc. | Cocrystal Pharma Receives Pre-IND Responses from the FDA on.. |
| 01.3.2024 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08.1.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.1.2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.1.2024 | 14:00 | GlobeNewswire Inc. | Cocrystal Pharma Provides an Update on the Clinical.. |
| 02.1.2024 | 15:53 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 21.12.2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.12.2023 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.12.2023 | 14:00 | GlobeNewswire Inc. | Cocrystal Pharma Announces First-Patient-In for Phase 2a.. |
| 04.12.2023 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29.11.2023 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Cocrystal Pharma
Keine Diskussionen Gefunden.Neuen Thread Erstellen
COCP Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 1,59 | 1,59 | 1,4885 | 1,55 | 7.749 | -0,04 | -2,52% |
| 1 Monat | 1,49 | 1,67 | 1,35 | 1,52 | 12.586 | 0,06 | 4,03% |
| 3 Monate | 1,49 | 1,74 | 1,325 | 1,49 | 13.769 | 0,06 | 4,03% |
| 6 Monate | 1,70 | 1,99 | 1,325 | 1,63 | 16.186 | -0,15 | -8,82% |
| 1 Jahr | 2,44 | 3,285 | 1,325 | 2,18 | 22.713 | -0,89 | -36,48% |
| 3 Jahre | 15,72 | 41,52 | 1,325 | 19,17 | 1.831.053 | -14,17 | -90,14% |
| 5 Jahre | 30,96 | 49,20 | 1,325 | 18,86 | 2.049.240 | -29,41 | -94,99% |
